글로벌 과학 기기 시장 – 2030년까지의 산업 동향 및 예측

과학 장비 시장 분석 및 규모

과학 장비는 제약, 생명공학 , 재료 과학, 환경 과학을 포함한 다양한 분야의 연구 개발 활동에 필수적인 도구입니다 . 연구가 더욱 복잡하고 학제간화됨에 따라 고급 및 전문 장비에 대한 수요가 계속 증가하고 있습니다. 기술의 급속한 발전으로 인해 더욱 정교하고 정밀한 과학 장비가 개발되었습니다. 이러한 혁신은 연구자의 역량을 향상시켜 더 높은 정확도와 효율성으로 실험을 수행하고 데이터를 수집할 수 있게 합니다. 정부, 민간 기관 및 학술 기관은 과학 연구에 대한 자금을 늘려 왔습니다. 이러한 자금 증가는 연구 프로젝트와 연구를 지원하기 위한 과학 장비에 대한 수요 증가로 이어졌습니다.

Data Bridge Market Research는 글로벌 과학 기기 시장이 2030년까지 61,109,803.02천 달러에 도달할 것으로 예상되며, 예측 기간 동안 CAGR은 4.7%라고 분석했습니다. 이 시장 보고서는 또한 가격 분석과 기술 발전에 대한 심층적인 내용을 다룹니다.

Market Definition

Scientific instruments can vary greatly in complexity and purpose. They can include devices as simple as thermometers and microscopes, to highly advanced equipment such as electron microscopes, mass spectrometers, DNA sequencers, and particle accelerators. These instruments are used in academic and research institutions, government agencies, pharmaceutical and biotechnology companies, environmental monitoring organizations, and many other sectors involved in scientific exploration and analysis.

Global Scientific Instruments Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

• Advancements in Healthcare and Medical Research

Advancements in healthcare and medical research have significantly contributed to the growth of the scientific instruments market in several ways. These advancements create demand for sophisticated tools and technologies that enable researchers, clinicians, and healthcare professionals to conduct more accurate and comprehensive analyses. The move toward precision medicine, which tailors medical treatments to individual patients based on their genetic makeup and other factors, requires advanced diagnostic tools. Scientific instruments such as genetic sequencers, molecular analyzers, and biomarker detection systems are crucial for identifying genetic variations and other factors that influence individual responses to treatments.

Genomic and proteomic research involves analyzing DNA, RNA, proteins, and other molecules to understand disease mechanisms and develop targeted therapies. High-throughput sequencing platforms, mass spectrometers, and other advanced instruments are essential for deciphering complex biological processes.

• Increasing Drug Development and Innovations

Drug development requires a deep understanding of molecular interactions, biological processes, and disease mechanisms. Scientific instruments offer researchers the tools to conduct intricate experiments, analyze complex data, and gain insights that are essential for developing new drugs and therapies. The process of identifying potential drug candidates involves screening large libraries of compounds for their biological activity. High-throughput screening instruments enable researchers to test thousands of compounds quickly and efficiently, accelerating the drug discovery process.

Innovations in genomics and proteomics have revolutionized drug development by enabling researchers to study genes, proteins, and their interactions. Instruments such as DNA sequencers, mass spectrometers, and gene expression analyzers provide critical information for designing targeted therapies. Understanding the three-dimensional structure of biomolecules is essential for designing drugs that can interact with specific molecular targets. Instruments such as X-ray crystallography equipment and nuclear magnetic resonance (NMR) spectrometers help researchers visualize and analyze these structures.

Opportunity

•  Rising Investments in the Healthcare Sector for Scientific Instrument

The rising investment in the healthcare sector directed towards scientific instrument products is presenting a promising opportunity for the scientific instruments market. The healthcare industry relies on advanced scientific instruments for diagnostics, research, and treatment, and the growing financial commitment to this sector is driving significant growth potential.

The increasing demand for precision medicine and personalized healthcare have also contributed to the rising investments in this sector. The need for accurate diagnostics and monitoring instruments intensifies as medical treatments become more tailored to individual patients. Scientific instruments such as microscopes, spectrometer systems play a pivotal role in enabling precise diagnostics and treatment strategies. This demand is fueling investment in research and development to create innovative and efficient instruments that can cater to these emerging healthcare trends.

Scientific instruments play a crucial role in drug discovery, development, and testing. As pharmaceutical companies strive to bring new treatments to market efficiently, investments in high-throughput screening systems, spectrometers, and analytical instruments are essential to accelerate research timelines and enhance drug efficacy assessment.

Investments in healthcare-driven scientific instruments are fostering innovation as well. Stakeholders pour resources into research and development, and breakthroughs in instrument design, miniaturization, and automation are being achieved. These innovations enhance instrument performance, accessibility, and ease of use, making them more applicable in various healthcare settings, including point-of-care facilities and remote areas.

Restraint/Challenge

• Economic Fluctuations

Economic fluctuations can restrain the growth of the global scientific instruments market by influencing purchasing decisions, research funding, and investment in new technologies. During economic downturns, governments, academic institutions, and private organizations may cut back on research funding. This can directly affect the budgets available for purchasing scientific instruments and conducting research projects. Organizations, including research institutions and industrial laboratories, may face budget constraints during economic downturns. This can lead to delays or cancellations in the acquisition of new scientific instruments, affecting market growth.

Companies and institutions might delay or defer capital expenditures, including investments in expensive scientific instruments until economic conditions stabilize. Industries that heavily rely on scientific instruments, such as pharmaceuticals, may experience reduced demand for new products during economic downturns. This can affect the demand for instruments used in research and development. Economic uncertainty can lead to reduced availability of venture capital and private investment, impacting the funding available for startups and innovative companies in the scientific instruments sector.

Recent Developments

• In June 2023, ZEISS International introduced a new integrated system for serial block-face imaging. The newly introduced ZEISS Volutome is an in-chamber ultramicrotome for ZEISS field emission scanning electron microscopes (FE-SEM). It is designed to image the ultrastructure of biological, resin-embedded samples in 3D in life sciences. This has helped the company to strengthen its product portfolio.
• In March 2023, Merck KGaA and Intel Corporation are enabling more sustainable semiconductor manufacturing solutions by funding a new academic research program in Europe.
• In February 2023, Thermo Fisher Scientific Inc., the world leader in serving science, and Celltrio, a leading manufacturer of robotics-based solutions for the life sciences industry, announced their collaboration to bring a fully automated cell culture system to bio-therapeutics customers.
• In January 2023, SCIEX (a part of the Danaher Family) launched the Fast Glycan Labeling and Analysis kit for quantitative glycan analysis and an update for Biologics Explorer software to enhance critical protein therapeutic analysis workflows. With these new additions, SCIEX continues to expand its ability to support the characterization of complex and next-generation biopharmaceuticals in different parts of the drug development pipeline.
• In December 2022, Merck announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., Cambridge, Massachusetts, USA, to discover novel antibody-drug-conjugates (ADCs).

Global Scientific Instruments Market Scope

The global scientific instruments market is segmented into five notable segments based on product, modality, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Microscopes
• Spectrometers
• X-ray Diffraction
• Thermal Analyzers
• Optical Measurement Systems
• Others

On the basis of product, the market is segmented into microscopes, spectrometers, x-ray diffraction, thermal analyzers, optical measurement systems, and others.

 Modality

• Handheld
• Benchtop
• Portable
• Others

On the basis of modality, the market is segmented into handheld, benchtop, portable, and others.

Application

• Clinical
• Research

On the basis of application, the market is segmented into clinical and research.

End User

• Hospitals
• Laboratories
• Healthcare Companies
• Academic and Research Institutes
• Others

On the basis of end user, the market is segmented into hospitals, laboratories, healthcare companies, academic and research institutes, and others.

Distribution Channel

• Direct Tender
• Retail Sales
• Online Sales
• Others

On the basis of distribution channel, the market is segmented into direct tender, retail sales, online sales, and others.

Global Scientific Instruments Market Regional Analysis/Insights

The global scientific instruments market is analyzed and market size insights and trends are provided by country, product, modality, application, end user, and distribution channel.

The countries covered in the global scientific instruments market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Denmark, Norway, Sweden, Poland, Finland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Oman, Qatar, Bahrain, and Rest of Middle East and Africa.

North America is expected to dominate the market with the largest market share due to advancements in healthcare and medical research. The U.S. is expected to dominate the market in the North America region due to increasing drug development and innovations. Germany is expected to dominate the market with the largest market share in the Europe region due to increasing demand for personalized medicines. Japan is expected to dominate the market in the Asia-Pacific region with the largest market share due to Rising demand for automation and high precision.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 하류 및 상류 가치 사슬 분석, 기술 추세, 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세의 영향 및 무역 경로가 국가 데이터의 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 글로벌 과학 장비 시장 점유율 분석

글로벌 과학 기기 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

이 시장에서 활동하는 주요 기업으로는 Merck KGaA, DH Life Sciences, LLC., Thermo Fisher Scientific Inc., ZEISS International, Waters Corporation, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., PerkinElmer Inc., Bruker, Thorlabs, Inc., Malvern Panalytical Ltd., HORIBA, Ltd., Promega Corporation, EVIDENT, Anton Paar GmbH, Ocean Insight, Rigaku Corporation, Hitachi High-Tech Analytical Science, LABINDIA ANALYTICAL INSTRUMENTS PVT. LTD., Panomex Inc., Nikon Instruments Inc. 등이 있습니다.

SKU-52730